Clinical Trial Update: Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating topical sirolimus in patients with Basal Cell Nevus Syndrome and in healthy participants has completed, reporting initial safety and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Basal Cell Nevus Syndrome
• Non-melanoma Skin Cancer

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Yale University | Conditions: Neoplastic Syndrome, Non-melanomatous Skin Cancer | Phase 1 | Status: COMPLETED